Evaluating a new frequency allocation for cochlear implant users
Official title: Clinical Evaluation of Frequency Allocation for Bimodal CI Users
Run by NYU Langone Health · NCT06663917 · Data updated 2026-11-12
This study is testing whether a new sound setting for cochlear implant users can improve their hearing experience and satisfaction compared to the standard setting.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 13 (estimated) |
| Sponsor | NYU Langone Health Academic / other |
| Locations | 1 site (New York, New York) |
| Status | Recruiting |
| Started | October 6, 2024 |
| Main results expected | October 6, 2027 |
| Study ends | October 6, 2027 |
| Registry record updated | June 26, 2026 |
| Trial ID | NCT06663917 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who regularly use a cochlear implant and a hearing aid in the opposite ear.
✕Probably not a fit
Patients under 18, non-English speakers, or those with cognitive impairments may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study examines experienced bimodal cochlear implant patients to assess the effects of an alternative frequency allocation table (FAT) on sound quality, device satisfaction, and speech perception. Participants will be provided with a new FAT set at 438 Hz compared to the standard FAT set at 188 Hz. The aim is to determine if this adjustment improves the auditory experience for users by reducing place-pitch mismatch. The study will involve regular assessments of participants' responses to the different frequency allocations.
Why it matters
Potential benefit: If successful, this study could enhance the auditory experience and communication abilities of cochlear implant users.
How similar studies have gone: While this approach is innovative, similar studies have shown promise in improving auditory outcomes for cochlear implant users.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age 18 or older 2. Regular usage of a cochlear implant device with at least 18 active electrodes, and compliance with programming/appointments 3. Received a cochlear implant at least 6 months ago and use a hearing aid in the contralateral ear 4. Pure tone average (.5, 1, and 2kHz) between 30 and 70 dB (decibel) hearing level in the contralateral (hearing aid) ear 5. Standard FAT use for all programs prior to study participation 6. No known anatomical abnormalities in either ear 7. English speaking 8. No known cognitive impairments 9. At least 25% of subjects should use the Cochlear EA32 electrode Exclusion Criteria: 1. Under age 18 2. Non-English speaking. Participants that are Non-English speaking are excluded from this study due to the use of speech testing materials that are validated in the English language. Additionally, study team members are not equipped to appropriately score speech testing materials validated in other languages. 3. Cognitively impaired 4. Non-consistent device usage 5. Greater than 70 dB hearing level pure tone average in the contralateral ear 6. Normal hearing or mild hearing loss in the contralateral ear 7. Non-standard FAT programs 8. Use of any frequency transposition programming in hearing aid.
Where it's running
-
NYU Langone Health
New York, New York, United States Recruiting
Study contacts
- Principal investigator: Mario A. Svirsky, PhD — NYU Langone Health
- Study coordinator: Mario Svirsky, PhD
- Email: Mario.svirsky@nyulangone.org
- Phone: 212-263-7217
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Clemastine plus engineered sound to improve hearing in noisy environments for age-related central auditory processing disorder
This trial will test whether taking clemastine while listening to engineered sounds helps people aged 45–65 with age-related central auditory processing disorder hear better in noisy places.
-
Registry for patients with CABP2-related hearing impairment
This study is collecting information from people with hearing loss caused by CABP2 gene changes to learn more about this condition and how it affects them.
-
Registry for patients with otoferlin-related hearing impairment
This study is collecting information from people with otoferlin-related hearing loss to better understand the condition and help improve future treatments.
-
Improving hearing tests for infants with hearing loss using brain imaging
This study tests if a new brain imaging technique can help audiologists make better decisions for infants with hearing loss while also checking if parents find the testing comfortable and acceptable.
-
Evaluating a noise reduction algorithm for cochlear implant users
This study is testing a new noise reduction tool to see if it helps people aged 12 and older with cochlear implants understand speech better in noisy places.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.